{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:09:34Z","timestamp":1788808174779,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Physical activity (PA) and structured exercise are established cornerstones of cystic fibrosis (CF) management. While CFTR modulators have transformed treatment, the psychological factors affecting sustained PA adherence, particularly motivational regulation and PA enjoyment, require further investigation. This study aimed to determine whether percent predicted forced expiratory volume in one second (ppFEV\u2081) is independently associated with autonomous motivation and PA enjoyment in adults with CF, after adjusting for CFTR modulator therapy status and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted at a specialised CF centre (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009200). Participants completed validated questionnaires assessing motivational regulation (Behavioural Regulation Questionnaire-2, BREQ-2) and PA enjoyment (Physical Activity Enjoyment Scale, PACES).\n                    <\/jats:p>\n                    <jats:p>Clinical data, including the ppFEV\u2081, were obtained from medical records. Multivariate general linear models (GLM), partial correlations, and hierarchical regression analyses were utilised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cross-sectional analyses showed that ppFEV\u2081 was independently associated with intrinsic motivation (\u03b2\u2009=\u2009.233,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001), the relative autonomy index (RAI) (\u03b2\u2009=\u2009.203,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.004) and the PACES total score (\u03b2\u2009=\u2009.201,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.004). After CFTR modulator therapy status and sex were accounted for, the additional variance explained by the ppFEV\u2081 was statistically significant but modest (\u0394R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009.054, .041, and .040, respectively). Neither the CFTR modulator therapy status nor sex was significantly associated with the assessed motivational or enjoyment outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although ppFEV\u2081 showed small, independent associations with autonomous motivational regulation and PA enjoyment in adults with CF, lung function should not be used as a proxy for motivational support needs. To provide person-centred, SDT-informed support that encourages sustained participation in PA, the motivational regulation and enjoyment of PA should be assessed directly in adults with CF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04661-w","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:14:22Z","timestamp":1788750862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Moving beyond treatment: pulmonary function, autonomous motivation, and physical activity enjoyment in adults with cystic fibrosis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-9269","authenticated-orcid":false,"given":"Wolfgang","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Welsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Stehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sun","family":"Schermaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Lechtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"4661_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0045-2024","author":"I Fajac","year":"2024","unstructured":"Fajac I, Burgel P-R, Martin C. New drugs, new challenges in cystic fibrosis care. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0045-2024.","journal-title":"Eur Respir Rev"},{"key":"4661_CR2","first-page":"47","volume":"44","author":"T Radtke","year":"2022","unstructured":"Radtke T, Smith S, Nevitt SJ, Hebestreit H, Kriemler S. Physical activity and exercise training in cystic fibrosis. Paediatr Respir Rev. 2022;44:47\u201352.","journal-title":"Paediatr Respir Rev"},{"key":"4661_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jcf.2013.03.003","volume":"12","author":"S Kriemler","year":"2013","unstructured":"Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, et al. Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial. J Cyst Fibros. 2013;12:714\u201320.","journal-title":"J Cyst Fibros"},{"key":"4661_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1183\/09031936.00062409","volume":"35","author":"H Hebestreit","year":"2010","unstructured":"Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, et al. Long-term effects of a partially supervised conditioning programme in cystic fibrosis. Eur Respir J. 2010;35:578\u2013653.","journal-title":"Eur Respir J"},{"issue":"3","key":"4661_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(21)00454-9","volume":"10","author":"S Sutharsan","year":"2022","unstructured":"Sutharsan S, McKone EF, Downey DG, Duckers J, MacGregor G, Tullis E, et al. Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial. Lancet Respir Med. 2022;10(3):267\u201377.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"4661_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jcf.2023.03.002","volume":"22","author":"JK Bower","year":"2023","unstructured":"Bower JK, Volkova N, Ahluwalia N, Sahota G, Xuan F, Chin A, et al. Real-world safety and effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: interim results of a long-term registry-based study. Journal of cystic fibrosis\u202f: official journal of the European Cystic Fibrosis Society. 2023;22(4):730\u20137.","journal-title":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"},{"issue":"4","key":"4661_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jcf.2025.04.012","volume":"24","author":"G Vega-Hernandez","year":"2025","unstructured":"Vega-Hernandez G, MacGregor G, Wilfin A, Adams F, Haugh C, Baxter CA, et al. LONGITUDE: an observational study of the long-term effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people aged \u226512 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis. J Cyst Fibros. 2025;24(4):716\u201323.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"4661_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jcf.2021.11.011","volume":"21","author":"JE Caterini","year":"2022","unstructured":"Caterini JE, Ratjen F, Barker AR, Williams CA, Rendall K, Schneiderman JE, et al. Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies. J Cyst Fibros. 2022;21(2):282\u201392.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"4661_CR9","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.jcf.2021.08.004","volume":"21","author":"M Gruet","year":"2022","unstructured":"Gruet M, Saynor ZL, Urquhart DS, Radtke T. Rethinking physical exercise training in the modern era of cystic fibrosis: a step towards optimising short-term efficacy and long-term engagement. J Cyst Fibros. 2022;21(2):e83\u201398.","journal-title":"J Cyst Fibros"},{"key":"4661_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fspor.2024.1284878","author":"W Gruber","year":"2024","unstructured":"Gruber W, Stehling F, Blosch C, Dillenhoefer S, Olivier M, Brinkmann F, et al. Longitudinal changes in habitual physical activity in adult people with cystic fibrosis in the presence or absence of treatment with elexacaftor\/tezacaftor\/ivacaftor. Front Sports Act Living. 2024. https:\/\/doi.org\/10.3389\/fspor.2024.1284878.","journal-title":"Front Sports Act Living"},{"key":"4661_CR11","doi-asserted-by":"publisher","unstructured":"Causer AJ, Shute JK, Cummings MH, Shepherd AI, Wallbanks SR, Pulsford RM, et al. Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis. Pediatric pulmonology. 2022;57(11):2652\u20138. https:\/\/doi.org\/10.1002\/ppul.26078.","DOI":"10.1002\/ppul.26078"},{"key":"4661_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108178","volume":"244","author":"J Perrone","year":"2025","unstructured":"Perrone J, Rabilloud M, Mely L. Change in the 6-min walk test among 71 patients with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor. Respir Med. 2025;244:108178.","journal-title":"Respir Med"},{"key":"4661_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.05.009","author":"UK Rysgaard","year":"2022","unstructured":"Rysgaard UK, Pedersen CL, Jensen JH, S\u00f8rensen L, Philipsen LKD, Leo-Hansen C, et al. Change in exercise capacity measured by cardio-pulmonary exercise testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with lumacaftor\/ivacaftor and tezacaftor\/ivacaftor. J Cyst Fibros. 2022. https:\/\/doi.org\/10.1016\/j.jcf.2022.05.009.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"4661_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/PEP.0000000000000086","volume":"26","author":"ZL Saynor","year":"2014","unstructured":"Saynor ZL, Barker AR, Oades PJ, Williams CA. The effect of ivacaftor in adolescents with cystic fibrosis (G551D mutation): an exercise physiology perspective. Pediatr Phys Ther. 2014;26(4):454\u201361.","journal-title":"Pediatr Phys Ther"},{"key":"4661_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192013150","author":"S Dillenhoefer","year":"2022","unstructured":"Dillenhoefer S, Stehling F, Welsner M, Schlegtendal A, Sutharsan S, Olivier M, et al. Barriers for sports and exercise participation and corresponding barrier management in cystic fibrosis. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph192013150.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4661_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/09593985.2021.2005201","volume":"39","author":"R Ladune","year":"2023","unstructured":"Ladune R, Filleul V, Falzon C, Hayotte M, M\u00e9ly L, Vallier J-M, et al. Perceptions of barriers to and facilitators of physical activity in adults with cystic fibrosis. Physiother Theory Pract. 2023;39(1):117\u201327.","journal-title":"Physiother Theory Pract"},{"issue":"1","key":"4661_CR17","first-page":"68","volume":"55","author":"RM Ryan","year":"2000","unstructured":"Ryan RM. Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. 2000;55(1):68\u201378.","journal-title":"Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being"},{"issue":"3","key":"4661_CR18","volume":"60","author":"Z Xu","year":"2025","unstructured":"Xu Z, Shamsulariffin S, Azhar Y, Xi M. Does Self-Determination Theory Associate With Physical Activity? A Systematic Review of Systematic Review. 2025;60(3):e70044.","journal-title":"A Systematic Review of Systematic Review"},{"key":"4661_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1479-5868-9-78","volume":"9","author":"PJ Teixeira","year":"2012","unstructured":"Teixeira PJ, Carra\u00e7a EV, Markland D, Silva MN, Ryan RM. Exercise, physical activity, and self-determination theory: a systematic review. The international journal of behavioral nutrition and physical activity. 2012;9:78.","journal-title":"The international journal of behavioral nutrition and physical activity"},{"key":"4661_CR20","volume":"80","author":"N Ntoumanis","year":"2025","unstructured":"Ntoumanis N. Moller AC. Self-determination theory informed research for promoting physical activity: Contributions, debates, and future directions. 2025;80:102879.","journal-title":"Self-determination theory informed research for promoting physical activity: Contributions, debates, and future directions"},{"key":"4661_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13172194","author":"W Gruber","year":"2025","unstructured":"Gruber W, Stehling F, Schermaul J-S, Ortiz JG, Lechtenberg L, Taube C, et al. Predictors of physical activity enjoyment in adults with cystic fibrosis: the role of quality of life and motivation-A single-center study. Healthcare (Basel). 2025. https:\/\/doi.org\/10.3390\/healthcare13172194.","journal-title":"Healthcare (Basel)"},{"key":"4661_CR22","doi-asserted-by":"publisher","unstructured":"Welsner M, Schermaul J-S, Ortiz JG, Lechtenberg L, Taube C, Stehling F et al. Mediating effects of physical activity enjoyment on physical activity levels in adults with cystic fibrosis. Front. Sports Act. Living 2026; Volume 8 - 2026. Available from: URL: https:\/\/www.frontiersin.org\/journals\/sports-and-active-living\/articles\/https:\/\/doi.org\/10.3389\/fspor.2026.1786911.","DOI":"10.3389\/fspor.2026.1786911"},{"issue":"4","key":"4661_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.71076","volume":"60","author":"W Gruber","year":"2025","unstructured":"Gruber W, Koop J, Haegele FA, Falkenberg C, Dewey S, Weisser B, et al. Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi-Experimental Study Comparing Individuals Treated With and Without Elexacaftor\/Tezacaftor\/Ivacaftor. Pediatr Pulmonol. 2025;60(4):e71076.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"4661_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12890-021-01482-x","volume":"21","author":"N Hurley","year":"2021","unstructured":"Hurley N, Moyna NM, Kehoe B, McCaffrey N, Redmond K, Hardcastle SJ. Factors influencing physical activity in adults with cystic fibrosis. BMC Pulm Med. 2021;21(1):113.","journal-title":"BMC Pulm Med"},{"issue":"11","key":"4661_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242069","volume":"15","author":"D Jekauc","year":"2020","unstructured":"Jekauc D, Nigg C, Nigg CR, Reichert M, Krell-Roesch J, Oriwol D, et al. Measurement properties of the German version of the Physical Activity Enjoyment Scale for adults. PLoS ONE. 2020;15(11):e0242069.","journal-title":"PLoS ONE"},{"issue":"1","key":"4661_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/jpepsy\/jss088","volume":"38","author":"D Jekauc","year":"2013","unstructured":"Jekauc D, Voelkle M, Wagner MO, Mewes N, Woll A. Reliability, validity, and measurement invariance of the German version of the physical activity enjoyment scale. J Pediatr Psychol. 2013;38(1):104\u201315.","journal-title":"J Pediatr Psychol"},{"key":"4661_CR27","unstructured":"Witzki A, Leyk D. Behavioural Regulation in Exercise Questionnaire (BREQ-2) Reliability and Validity of a German Translation. In: G\u00fcnt\u00fcrk\u00fcn (Hg.) 2014 \u2013 49. Kongress der Deutschen Gesellschaft."},{"key":"4661_CR28","unstructured":"Cystic Fibrosis Foundation. 31. Patient Registry Annual Data Report 2021. Bethesda, Maryland; 2022."},{"issue":"5","key":"4661_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000529524","volume":"102","author":"AS Dittrich","year":"2023","unstructured":"Dittrich AS, Dumke M, Kapl F, Schneider P, Wege S, Gr\u00e4ber S, et al. Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany. Respiration; international review of thoracic diseases. 2023;102(5):1.","journal-title":"Respiration; international review of thoracic diseases"},{"issue":"1","key":"4661_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70076","volume":"34","author":"L Naehrlich","year":"2025","unstructured":"Naehrlich L, Burkhart M. Success of the German Cystic Fibrosis Registry. Pharmacoepidemiol Drug Saf. 2025;34(1):e70076.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4661_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fspor.2020.00072","volume":"2","author":"J Piggin","year":"2020","unstructured":"Piggin J. What Is Physical Activity? A Holistic Definition for Teachers, Researchers and Policy Makers. Front Sports Act Living. 2020;2:72.","journal-title":"Front Sports Act Living"},{"key":"4661_CR32","unstructured":"Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public health reports (Washington, D.C. : 1974) 1985; 100(2):126\u201331."},{"issue":"2","key":"4661_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0749-3797(01)00326-9","volume":"21","author":"RW Motl","year":"2001","unstructured":"Motl RW, Dishman RK, Saunders R, Dowda M, Felton G, Pate RR. Measuring enjoyment of physical activity in adolescent girls. Am J Prev Med. 2001;21(2):110\u20137.","journal-title":"Am J Prev Med"},{"issue":"2","key":"4661_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1123\/jsep.26.2.191","volume":"26","author":"D Markland","year":"2004","unstructured":"Markland D, Tobin V. A modification to the behavioural regulation in exercise questionnaire to include an assessment of amotivation. J Sport Exerc Psychol. 2004;26(2):191\u20136.","journal-title":"J Sport Exerc Psychol"},{"key":"4661_CR35","volume-title":"Handbook of self determination research","author":"EL Deci","year":"2002","unstructured":"Deci EL, Ryan R. Handbook of self determination research. Rochester, NY: University of Rochester Press; 2002."},{"key":"4661_CR36","doi-asserted-by":"crossref","unstructured":"Videm V, Hoff M, Liff MH. Use of the Behavioral Regulation in Exercise Questionnaire-2 to assess motivation for physical activity in persons with rheumatoid arthritis: an observational study 2022; 42(11):2039\u201347.","DOI":"10.1007\/s00296-021-05079-9"},{"key":"4661_CR37","doi-asserted-by":"publisher","DOI":"10.1037\/a0030215","author":"E Gu\u00e9rin","year":"2012","unstructured":"Gu\u00e9rin E, Bales E, Sweet S, Fortier M. A meta-analysis of the influence of gender on self-determination theory\u2019s motivational regulations for physical activity. Can Psychol Psychol Can. 2012. https:\/\/doi.org\/10.1037\/a0030215.","journal-title":"Can Psychol Psychol Can"},{"key":"4661_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1479-5868-7-7","volume":"7","author":"LR Duncan","year":"2010","unstructured":"Duncan LR, Hall CR, Wilson PM, Jenny O. Exercise motivation: a cross-sectional analysis examining its relationships with frequency, intensity, and duration of exercise. Int J Behav Nutr Phys Act. 2010;7:7.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"3","key":"4661_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1207\/s15327841mpee1003_4","volume":"10","author":"SP Vlachopoulos","year":"2006","unstructured":"Vlachopoulos SP, Michailidou S. Development and initial validation of a measure of autonomy, competence, and relatedness in exercise: the basic psychological needs in exercise scale. Meas Phys Educ Exerc Sci. 2006;10(3):179\u2013201.","journal-title":"Meas Phys Educ Exerc Sci"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04661-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04661-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04661-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:02:51Z","timestamp":1788807771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04661-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4661"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04661-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of the University of Duisburg-Essen (24\u201311951-BO). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"400"}}